Strategic Acquisition Opportunities Probi was acquired by Symrise in 2025, strengthening its global reach and integration into a broader health and beauty portfolio. This presents a sales opening to cross-sell Probi’s biotics solutions within Symrise’s existing customer base and channels, particularly in care and wellness segments.

Global Market Expansion With presence in over 40 markets and a track record of international collaborations (e.g., Japan with Nomura Dairy and multi-market awards), there is strong potential to pursue new regional partnerships and co-development opportunities in emerging markets for functional foods, beverages, and supplements.

Innovative Postbiotics Recent launches of stable postbiotics and postbiotic versions of probiotic strains (such as Rham271h) open doors for formulations requiring enhanced stability and broader ingredient compatibility, enabling sales discussions with beverage, nutrition, and clinical nutrition brands seeking resilient functional ingredients.

Women’s Health Focus Award recognition for iron absorption concepts targeting women’s health suggests a compelling case to collaborate with nutraceutical brands and retailers focusing on women's wellness, sports nutrition, and iron deficiency interventions across Europe, North America, and Asia.

Strategic Partnerships Active collaborations with DPO International, Symrise, and other global players for ingredient solutions in beverages and functional foods indicate a readiness to engage new co-creation and private-label opportunities, leveraging Probi’s LP299V and related strains for joint product development.